A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients-Reference-Cited by-同舟云学术

A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients

Author:

Shah M.¹,Shankar A.¹,Gee I.²,Nash K.¹,Hoare M.¹³,Gibbs P.⁴,Davies S.⁵,Alexander G. J. M.¹

Affiliation:

1. Division of Gastroenterology and Hepatology; Department of Medicine; University of Cambridge; Cambridge University Hospitals; Cambridge UK

2. Worcestershire Royal Hospital; Worcester UK

3. CRUK; Cambridge Institute; University of Cambridge; Cambridge UK

4. Department of Surgery; Cambridge University Hospitals; University of Cambridge; Cambridge UK

5. Department of Histopathology; Cambridge University Hospitals, University of Cambridge; Cambridge UK

Funder

Wyeth Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

Reference81 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Kidney Transplantation in the Hepatitis C Infected Recipient;Kidney Transplantation, Bioengineering and Regeneration;2017